Work

Health outcomes assessment and economic evaluation in COPD: challenges and opportunities

Year: 2003
Type: article
Abstract: As a leading and growing cause of mortality and morbidity worldwide, chronic obstructive pulmonary disease (COPD) is now widely recognised as a major global public health problem with substantial medical and economic burdens. A decade ago, the annual per capita expenditure for COPD treatment in the USA was $8,482, more than twice that for people without COPD [1]. With an increasingly older population in most countries, the prevalence of COPD and its associated healthcare costs will grow. In a disturbing report, the Global Burden of Disease Study concluded that from 1990–2020, COPD would increase worldwide from the sixth- to the third-leading cause of death and from the twelfth- to the fifth-leading cause of disability-adjusted life years lost [2]. To develop a coordinated international strategy for
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2152005149
FWCI: 0.676
Cites: 3
Cited by: 19
Related to: 8